Dr. James Pearl, MD

NPI: 1417959206
Total Payments
$83,324
2024 Payments
$13,900
Companies
24
Transactions
242
Medicare Patients
1,240
Medicare Billing
$73,606

Payment Breakdown by Category

Other$71,150 (85.4%)
Travel$4,829 (5.8%)
Consulting$4,044 (4.9%)
Food & Beverage$3,247 (3.9%)
Education$54.05 (0.1%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $71,150 45 85.4%
Travel and Lodging $4,829 39 5.8%
Consulting Fee $4,044 2 4.9%
Food and Beverage $3,247 151 3.9%
Education $54.05 5 0.1%

Top Paying Companies

Company Total Records Latest Year
AstraZeneca Pharmaceuticals LP $81,812 141 $0 (2024)
GlaxoSmithKline, LLC. $240.61 23 $0 (2018)
Boehringer Ingelheim Pharmaceuticals, Inc. $189.96 10 $0 (2019)
Sunovion Pharmaceuticals Inc. $141.82 12 $0 (2019)
Respiratory Technologies, Inc. $83.38 3 $0 (2017)
BOSTON SCIENTIFIC CORPORATION $82.38 3 $0 (2018)
United Therapeutics Corporation $79.64 3 $0 (2021)
Merck Sharp & Dohme Corporation $78.42 5 $0 (2019)
Mallinckrodt LLC $75.17 3 $0 (2018)
ADVANCED RESPIRATORY, INC $72.45 4 $0 (2019)

Payment History by Year

Year Amount Transactions Top Company
2024 $13,900 19 AstraZeneca Pharmaceuticals LP ($13,900)
2023 $11,229 12 AstraZeneca Pharmaceuticals LP ($11,229)
2022 $21,691 33 AstraZeneca Pharmaceuticals LP ($21,691)
2021 $10,983 16 AstraZeneca Pharmaceuticals LP ($10,964)
2020 $5,340 10 AstraZeneca Pharmaceuticals LP ($5,340)
2019 $185.80 11 AstraZeneca Pharmaceuticals LP ($46.34)
2018 $5,646 60 AstraZeneca Pharmaceuticals LP ($5,005)
2017 $14,350 81 AstraZeneca Pharmaceuticals LP ($13,637)

All Payment Transactions

242 individual payment records from CMS Open Payments — Page 1 of 10

Date Company Product Nature Form Amount Type
11/04/2024 AstraZeneca Pharmaceuticals LP BREZTRI (Drug), AIRSUPRA Education In-kind items and services $22.52 General
Category: Respiratory
10/29/2024 AstraZeneca Pharmaceuticals LP BREZTRI (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $3,250.00 General
Category: Respiratory
10/02/2024 AstraZeneca Pharmaceuticals LP BREZTRI (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $950.00 General
Category: Respiratory
09/04/2024 AstraZeneca Pharmaceuticals LP BREZTRI (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $925.00 General
Category: Respiratory
08/28/2024 AstraZeneca Pharmaceuticals LP BREZTRI (Drug) Travel and Lodging In-kind items and services $259.96 General
Category: Respiratory
07/01/2024 AstraZeneca Pharmaceuticals LP BREZTRI (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,800.00 General
Category: Respiratory
06/25/2024 AstraZeneca Pharmaceuticals LP BREZTRI (Drug) Food and Beverage In-kind items and services $81.03 General
Category: Respiratory
06/25/2024 AstraZeneca Pharmaceuticals LP BREZTRI (Drug) Travel and Lodging In-kind items and services $60.30 General
Category: Respiratory
06/12/2024 AstraZeneca Pharmaceuticals LP BREZTRI (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,350.00 General
Category: Respiratory
06/03/2024 AstraZeneca Pharmaceuticals LP BREZTRI (Drug) Travel and Lodging In-kind items and services $41.54 General
Category: Respiratory
05/03/2024 AstraZeneca Pharmaceuticals LP BREZTRI (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,400.00 General
Category: Respiratory
04/10/2024 AstraZeneca Pharmaceuticals LP BREZTRI (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,400.00 General
Category: Respiratory
03/27/2024 AstraZeneca Pharmaceuticals LP AIRSUPRA (Drug) Food and Beverage In-kind items and services $18.44 General
Category: Respiratory
03/27/2024 AstraZeneca Pharmaceuticals LP BREZTRI (Drug) Travel and Lodging In-kind items and services $17.42 General
Category: Respiratory
03/27/2024 AstraZeneca Pharmaceuticals LP AIRSUPRA (Drug) Food and Beverage In-kind items and services $0.65 General
Category: Respiratory
03/15/2024 AstraZeneca Pharmaceuticals LP BREZTRI (Drug) Travel and Lodging In-kind items and services $29.48 General
Category: Respiratory
03/15/2024 AstraZeneca Pharmaceuticals LP BREZTRI (Drug) Food and Beverage In-kind items and services $16.71 General
Category: Respiratory
03/12/2024 AstraZeneca Pharmaceuticals LP BREZTRI (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $150.00 General
Category: Respiratory
02/13/2024 AstraZeneca Pharmaceuticals LP AIRSUPRA (Drug) Food and Beverage In-kind items and services $126.82 General
Category: Respiratory
12/12/2023 AstraZeneca Pharmaceuticals LP BREZTRI (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $300.00 General
Category: Respiratory
11/30/2023 AstraZeneca Pharmaceuticals LP BREZTRI (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,350.00 General
Category: Respiratory
11/16/2023 AstraZeneca Pharmaceuticals LP BREZTRI (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $950.00 General
Category: Respiratory
11/14/2023 AstraZeneca Pharmaceuticals LP BREZTRI (Drug) Travel and Lodging In-kind items and services $36.68 General
Category: Respiratory
10/27/2023 AstraZeneca Pharmaceuticals LP AIRSUPRA (Drug) Education In-kind items and services $6.23 General
Category: Respiratory
09/13/2023 AstraZeneca Pharmaceuticals LP BREZTRI (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $3,700.00 General
Category: Respiratory

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 7 256 447 $48,001 $17,640
2022 7 362 549 $56,637 $23,045
2021 7 328 509 $50,025 $21,321
2020 7 294 400 $32,289 $11,600
Total Patients
1,240
Total Services
1,905
Medicare Billing
$73,606
Procedure Codes
30

All Medicare Procedures & Services

30 procedure records from CMS Medicare Utilization — Page 2 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2020 16 35 $6,020 $2,848 47.3%
99441 Physician telephone patient service, 5-10 minutes of medical discussion Facility 2020 40 67 $1,474 $1,109 75.2%
93010 Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report Facility 2020 114 129 $2,451 $803.81 32.8%
99442 Physician telephone patient service, 11-20 minutes of medical discussion Facility 2020 16 21 $882.00 $638.40 72.4%
99152 Moderate sedation services by physician also performing a procedure, patient 5 years of age or older, first 15 minutes Facility 2020 22 26 $780.00 $241.52 31.0%

About Dr. James Pearl, MD

Dr. James Pearl, MD is a Critical Care Medicine healthcare provider based in Salt Lake City, Utah. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/11/2005. The National Provider Identifier (NPI) number assigned to this provider is 1417959206.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Pearl, MD has received a total of $83,324 in payments from pharmaceutical and medical device companies, with $13,900 received in 2024. These payments were reported across 242 transactions from 24 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($71,150).

As a Medicare-enrolled provider, Pearl has provided services to 1,240 Medicare beneficiaries, totaling 1,905 services with total Medicare billing of $73,606. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.

Practice Information

  • Specialty Critical Care Medicine
  • Other Specialties Pulmonary Disease
  • Location Salt Lake City, UT
  • Active Since 08/11/2005
  • Last Updated 09/15/2021
  • Taxonomy Code 207RC0200X
  • Entity Type Individual
  • NPI Number 1417959206

Products in Payments

  • BREZTRI (Drug) $57,620
  • BEVESPI AEROSPHERE (Drug) $13,536
  • BREZTRI AEROSPHERE (Drug) $5,340
  • FASENRA (Drug) $4,952
  • SYMBICORT (Drug) $168.32
  • AIRSUPRA (Drug) $152.14
  • NUCALA (Biological) $94.48
  • ZERBAXA (Drug) $78.42
  • ACTHAR (Biological) $75.17
  • OFEV (Drug) $73.92
  • The Vest System Model 105 Home Care (Device) $72.45
  • BROVANA (Drug) $61.80
  • AVYCAZ (Drug) $58.31
  • STIOLTO RESPIMAT (Drug) $58.29
  • BREO (Drug) $54.76
  • GENERAL PULMONARY (Device) $53.18
  • Perforomist (Drug) $47.19
  • ORENITRAM (Drug) $46.80
  • BEVYXXA (Drug) $46.31
  • TRELEGY ELLIPTA (Drug) $40.60

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Critical Care Medicine Doctors in Salt Lake City